SR-9009 (also known as Stenabolic) is a synthetic chemical compound classified as an agonist of the Rev-ErbA receptors (REV-ERBα/β), which are regulatory elements involved in circadian rhythm and gene expression linked to cellular metabolism. It was developed as a research tool to study effects on circadian rhythms, mitochondrial regulation, and cellular metabolic activity in experimental settings.
This substance is not approved for use in humans or animals and is strictly limited to preclinical and in vitro research applications.
Research Applications: SR-9009 is used exclusively in scientific studies focused on:
-
the role of nuclear REV-ERB receptors in gene expression,
-
investigations of the biological clock and circadian rhythm,
-
metabolic and oxidative mechanisms under preclinical conditions,
-
effects on mitochondrial regulation in cell-based models.
GW-501516 is a chemical compound classified as a selective agonist of the PPARδ receptor (Peroxisome Proliferator-Activated Receptor delta). Originally developed as part of research into the regulation of lipid and glucose metabolism, GW-501516 is now primarily used as a reference substance in laboratory and experimental studies.
Also known as Cardarine, GW-501516 is not approved for medical use.
Research Applications: GW-501516 is used exclusively in laboratory research, including:
-
molecular experiments on the activation of nuclear receptors,
-
analysis of metabolic pathways related to lipid regulation,
-
studies on the effects of PPARδ agonists on gene expression related to energy metabolism in non-clinical models.
No clinical trials have confirmed the safety of GW-501516 in humans, and earlier preclinical studies have indicated potential adverse effects with long-term use in animal models.
CJC-1295 + DAC is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) combined with a Drug Affinity Complex (DAC), which extends the peptide’s half-life in model organisms. Thanks to DAC, CJC-1295 demonstrates a prolonged duration of activity, potentially enabling more precise investigation of growth hormone secretion and the regulation of metabolic processes in scientific research. CJC-1295 is used in studies focused on increasing growth hormone levels and examining its effects on metabolism and regeneration.
This product is intended strictly for research and experimental purposes only, and its use in humans or animals is not permitted.
Research Applications: CJC-1295 + DAC is used exclusively in laboratory studies to:
-
investigate growth hormone secretion and hormonal regulation in model organisms,
-
analyze the peptide’s influence on energy metabolism, protein synthesis, and regenerative processes,
-
test the potential of CJC-1295 + DAC in promoting muscle mass growth and fat reduction in an experimental context,
-
study interactions with receptors and the impact of DAC on prolonging the peptide’s activity in model organisms.
CJC-1295 + DAC is not intended for human or veterinary use in any therapeutic context. The product is strictly for research and experimental purposes only.
